|
44
|
127
|
8b96A |
Crystal structure of the human brd4-bd1 bromodomain in complex with the inhibitor crcm5464 |
|
42
|
127
|
8b98A |
Crystal structure of the human brd4-bd1 bromodomain in complex with the inhibitor crcm5483 |
|
42
|
131
|
8k14A |
X-ray crystal structure of 18a in brd4(1) |
|
43
|
127
|
8q34A |
Crystal structure of the first bromodomain of human brd4 in complex with the ligand zz001229a |
|
42
|
126
|
8fvkA |
First bromodomain of brd4 liganded with ccs-1477 |
|
32
|
107
|
8wy7A |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor 22 |
|
34
|
107
|
8wy3A |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor 21 |
|
34
|
107
|
8wxyA |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor 23 |
|
40
|
129
|
8c11A |
Brd4 in complex with 2-(2-(4-(3,5-dimethylisoxazol-4-yl)-1h-pyrazol-1-yl)acetamido)-n-ethylpropanamide |
|
45
|
126
|
6zelAAA |
Crystal structure of the first bromodomain of human brd4 in complex with compound f5 |
|
46
|
127
|
6zedAAA |
Crystal structure of the first bromodomain of human brd4 in complex with compound f1 |
|
42
|
124
|
7rxrA |
Crystal structure of brd4(d1) with 4-[4-(4-bromophenyl)-1-(piperidin-4-yl)-1h-imidazol-5-yl]-n-(3,5-dimethylphenyl)pyrimidin-2-amine |
|
40
|
126
|
7rxtA |
Crystal of brd4(d1) with 2-[(3r)-3-{5-[2-(3,5-dimethylphenoxy)pyrimidin-4-yl]-4-(4-iodophenyl)-1h-imidazol-1-yl}pyrrolidin-1-yl]ethan-1-amine |
|
43
|
127
|
6z7lAAA |
N-terminal bromodomain of human brd4 with gsk789 |
|
43
|
125
|
6z7mAAA |
N-terminal bromodomain of human brd4 (3r,4r)-n-cyclohexyl-4-((3-methyl-2-oxo-1,2-dihydro-1,7-naphthyridin-8-yl)amino)piperidine-3-carboxamide |
|
44
|
127
|
6zf9AAA |
Crystal structure of the first bromodomain of human brd4 in complex with compound ssr4 |
|
45
|
124
|
7rxsA |
Crystal of brd4(d1) with 2-[(3s)-3-{5-[2-(3,5-dimethylphenoxy)pyrimidin-4-yl]-4-(4-iodophenyl)-1h-imidazol-1-yl}pyrrolidin-1-yl]ethan-1-amine |
|
42
|
127
|
6z7gAAA |
N-terminal bromodomain of human brd4 with n-(2-(1h-imidazol-4-yl)ethyl)-4-acetamido-3-(benzyloxy)benzamide |
|
33
|
105
|
7la9A |
Crystal structure of the first bromodomain (bd1) of human brd4 (brd4-1) in complex with bivalent inhibitor nc-iii-49-1 |
|
45
|
127
|
7l9mA |
Crystal structure of the first bromodomain (bd1) of human brd4 in complex with bivalent inhibitor gxh-ii-083 |
|
43
|
125
|
7ehyA |
Brd4-bd1 in complex with lt-448-138 |
|
43
|
125
|
7ehwA |
Brd4-bd1 in complex with lt-642-602 |
|
28
|
109
|
7aqtA |
Nmr2 structure of brd4-bd2 in complex with ibet-762 |
|
1
|
11
|
7tv0E |
Crystal structure of brd4 bromodomain 1 in complex with dual-acetylated sars-cov-2 e |
|
39
|
124
|
7tuqA |
Crystal structure of brd4 bromodomain 1 in complex with monoacetylated sars-cov-2 e |
|
41
|
134
|
7tv0A |
Crystal structure of brd4 bromodomain 1 in complex with dual-acetylated sars-cov-2 e |
|
44
|
126
|
7q3fA |
Bromodomain-containing 4 bd1 in complex with the inhibitor crcm5484 |
|
42
|
127
|
7mr5A |
Crystal structure of the first bromodomain (bd1) of human brd4 bound to gxh-ii-052 |
|
44
|
126
|
7mr7A |
Crystal structure of the first bromodomain (bd1) of human brd4 bound to gxh-ii-075 |
|
42
|
126
|
7mr8A |
Crystal structure of the first bromodomain (bd1) of human brd4 bound to gxh-ii-076 |
|
44
|
127
|
7mr6A |
Crystal structure of the first bromodomain (bd1) of human brd4 bound to gxh-ii-082 |
|
43
|
125
|
7eigA |
Brd4-bd1 in complex with lt-730-903 |
|
45
|
124
|
7lh8A |
Crystal structure of the first bromodomain of human brd4 in complex with inhibitor jj-ii-131 |
|
46
|
125
|
7eilA |
Brd4-bd1 in complex with lt-909-110 |
|
43
|
125
|
7eikA |
Rd4-bd1 in complex with lt-872-297 |
|
43
|
127
|
8pxnA |
N-terminal bromodomain of human brd4 with (1r,1'r)-7,7'-(ethane-1,2-diylbis(oxy))bis(1,3-dimethyl-1,3-dihydro-2h-benzo[d]azepin-2-one) |
|
40
|
127
|
8pxmA |
N-terminal bromodomain of human brd4 with (1r,1'r)-7,7'-(pentane-1,5-diylbis(oxy))bis(1,3-dimethyl-1,3-dihydro-2h-benzo[d]azepin-2-one) |
|
43
|
125
|
8pxaAAA |
N-terminal bromodomain of human brd4 with (s)-5-(1-((1-(1-isopropylpiperidine-4-carbonyl)piperidin-3-yl)methyl)-1h-benzo[d]imidazol-2-yl)-1,3-dimethylpyridin-2(1h)-one |
|
40
|
123
|
8ibqA |
Bromodomain and extra-terminal domain (bet) brd4 |
|
38
|
112
|
8idhA |
Bromodomain and extra-terminal domain (bet) brd4 |
|
45
|
123
|
8ckfA |
Crystal structure of the first bromodomain of human brd4 l94c variant in complex with racemic 3,5-dimethylisoxazol ligand |
|
44
|
127
|
8piqA |
Crystal structure of brd4-bd1 with bi894999 |
|
40
|
133
|
7yl2A |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor y07004 |
|
40
|
125
|
8p9hA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb437 |
|
40
|
125
|
8p9gA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb390 |
|
39
|
125
|
8p9jA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb500 |
|
43
|
125
|
8p9kA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb503 |
|
40
|
124
|
8p9iA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb462 |
|
39
|
125
|
8p9fA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb161 |
|
41
|
125
|
8p9lA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual bet/hdac inhibitor nb512 |
